The Biden administration has announced the first 10 medications that will be subject to price negotiations under Medicare — a key Democratic priority stemming from last year’s Inflation Reduction Act. Larry Levitt, executive vice president for health policy at KFF, joined CBS News to discuss what the negotiations mean.
Descargo de responsabilidad: Este artículo puede requerir una suscripción.
Español de México 
English